New midsize SUV ratings from the Insurance Institute for Highway Safety show that headlights are improving when it comes to visibility, but many still need to do a better job of lighting the road ahead while limiting bothersome glare.
The 2017 Hyundai Santa Fe and the 2017 Volvo XC60 are the only models available with good-rated headlights among the 19 midsize SUVs and 18 midsize luxury SUVs evaluated in this new round of tests. Twelve SUVs are available with headlights rated acceptable, while 23 aren’t available with anything other than marginal- or poor-rated headlights.
In the new season of “El Señor de los Cielos”, Rafael Amaya’s Aurelio Casillas returns to prepare for an impending war with his nephew, which will end in a life-or-death struggle against his own family. The highly acclaimed Super Series™ premiering Tuesday, June 20 at 10pm/9c, also stars Fernanda Castillo, Carmen Aub, Mariana Seoane, Maricela Gonzalez, Sabrina Seara and Vanessa Villela.
The cast also includes Lisa Owen, Alejandro Lopez, Jorge Luis Moreno, Plutarco Haza, Ofelia Medina, Jesús Moré, Ivan Tamayo, Manuel Balbi, Wendy de los Cobos, Ivan Arana, Rafael Novoa, Carlos Mata, Patricia Vico, Emanuel Esparza.
To view the multimedia release go to:
https://www.multivu.com/players/English/8121351-el-senor-de-los-cielos-nueva-temporada/
Today, WebMD released My Abuelita Told Me, a new five-part video series developed in partnership with Dr. Juan Rivera (“Dr. Juan”), a board-certified internist and cardiologist, who is well-known for his best-selling books and regular appearances on broadcast television. My Abuelita Told Me explores the reliability of the various home remedies, beliefs and established practices that beloved abuelitas (a.k.a. grandmas) have passed down through the generations, and Dr. Juan clarifies what is or isn’t accurate using medical science.
To view the multimedia release go to:
https://www.multivu.com/players/English/7579758-webmd-my-abuelita-told-me-bilingual-video-series/
Will Cheetos shaped like a Flamin’ Hot Croissant or a Cheesy Pineapple become the next famous piece of Cheetos art this summer? Cheetos, one of the flagship brands from PepsiCo’s Frito-Lay division, is again asking America what they see in their Cheetos to find the most sought-after Cheetos works of art for the official Cheetos Museum, www.CheetosMuseum.com.
To officially kick off the hunt for the next priceless Cheetos shape, Cheetos and Ripley’s Believe It or Not! have teamed up to bring Chester’s exclusive exhibit to life in an unbelievable, must-see-it-to-believe-it way. Cheetos fans will hunt for hidden shapes in a completely immersive exhibit made with more than 128,900 Cheetos, and experience endless halls of one-of-a-kind Cheetos shapes in a mirror-lined infinity room at the Times Square (42nd Street between 7th and 8th Avenues) Ripley’s Believe it or Not!
To view the multimedia release go to:
https://www.multivu.com/players/English/8117651-cheetos-museum-unique-shapes-contest/
Following the successful integration of eyeshadow try-on earlier this spring, Sephora, the leader in global prestige beauty retail, continues to drive mobile engagement with the launch of even more augmented reality-based features to Sephora Virtual Artist on its award-winning iOS and Android apps. New today are Cheek Try On, which allows users to virtually try on over 1,000 shades of cheek color, an expanded library of Looks, and a Color Match for Virtual Try On feature, which uses Artificial Intelligence to detect and accurately estimate the shade in any photo and match it with a lip, eyeshadow or cheek products available at Sephora. Available in the Sephora app, these new features for Sephora Virtual Artist are the latest in a series of digital enhancements powered by the Sephora Innovation Lab to customize the retailer’s expanding beauty experiences.
To view the multimedia release go to:
https://www.multivu.com/players/English/7926154-sephora-virtual-artist-cheek-try-on-color-match/
Blink Health, America’s leading prescription drug savings platform, today launched a program to help #TreatType2 diabetes by committing to give away $10 million worth of medication to patients with type-2 diabetes. People living with diabetes who create an account on Blink Health’s website or free mobile app, starting today, will receive a free, one-year supply of the three most commonly prescribed generic medications for type-2 diabetes: metformin, glipizide and pioglitazone. The program will also cover these three medications for existing Blink Health patients who use them.
To view the multimedia release go to:
https://www.multivu.com/players/English/8117451-blink-health-type-2-diabetes-medications/
2017 Renault Zoe
Renault has introduced a new Z.E. 40 battery for ZOE. At the same, ZOE owners can benefit from a range of new connected services and equipment upgrades. Order books for the new ZOE line-up are open. The new ZOEs fitted with the new Z.E. 40 battery are made at Renault's Flins plant in France and will be available for delivery before the end of 2016.
Double the range for even longer journeys
As the pioneer of all-electric mobility and Europe's number one seller of electric vehicles, Renault has stepped up its innovation programme and the deployment of its Zero Emissions strategy.
Fitted with the new Z.E. 40 battery, the Renault ZOE now delivers a record NEDC driving range of 400km, which is twice the distance delivered by the model at the time of its original launch.
The new Z.E. 40 battery has a real-world range of 300 kilometres in urban or suburban areas, for example.
The range permitted today by the ZOE is the longest of any mainstream all-electric vehicle and motorists can take advantage of this step forward now.
The ZOE is the best-selling electric vehicle in Europe and provides a real alternative to internal combustion-engine cars, since average daily commuting distances are well within the ZOE's capabilities.
The new battery removes the final psychological barrier that stands in the way of buying an electric car since ZOE users can now travel further and enjoy a wider variety of driving situations without worry about charging. This makes weekend trips a real possibility.
The Z.E. 40 battery's charging rate is similar to that of the standard battery, so 'topping up' doesn't take long at all. For example, just 30 minutes are required on average to charge the battery for an extra 80 kilometres of driving range when plugged into one of the many public charging points in operation in Europe. The ZOE continues to be equipped with the Quick Charge function to take full advantage of the maximum capacity of fast charging points located predominantly along motorway corridors.
An innovation that doubles battery capacity with no increase in size
The ZOE's new Z.E. 40 battery boasts 41kWh of useful energy, equivalent to almost double the storage capacity of the ZOE's standard battery (22kWh of useful energy).
Developed in close partnership with LG Chem, the battery uses high-energy density lithium-ion technology.
Renault and LG engineers have succeeded in increasing storage capacity without making the battery any bigger or a lot heavier. It was optimised by working on the chemistry of the cells in order to increase their energy density, rather than stacking additional battery modules, a commonly used technique.
This major new technology has been developed while ensuring the battery's reliability or safety.
The battery's large storage capacity ensures longer range for the ZOE thanks to the meticulous work that went into integrating the battery in the vehicle. The electronic management system of the battery optimises the ZOE's energy use on the move, while the new air circulation system maintains the temperature of the ZOE's battery at a constant level, making the car economical to run in very hot or very cold weather.
Tektronix, Inc., a leading worldwide provider of measurement solutions, has again broken through the innovation barrier with the introduction of the new 5 Series MSO mixed signal oscilloscope. To better meet modern electronics design challenges, the 5 Series MSO redefines the midrange oscilloscope with a host of innovations including the industry’s first FlexChannel™ technology that allows 4, 6 or 8 analog channels and up to 64 digital channels, integrated protocol analysis and signal generator, a new 12-bit signal acquisition system, a massive high-definition capacitive touch display, and a highly intuitive Direct Access user interface ¾ delivering unprecedented flexibility and unmatched visibility into complex embedded systems.
To view the multimedia release go to:
https://www.multivu.com/players/English/7990951-tektronix-5-series-mso-mixed-signal-oscilloscope/
Imagine finding the most qualified candidate for a job, but that person is blind. Or perhaps a long-term employee experiences vision loss as a result of an accident. What would an employer need to do to accommodate that person? Is the employee able to keep the job?
Serving as a national model for how technology can create job opportunities and accessible workplaces for people without vision, Indianapolis-based nonprofit Bosma Enterprises is one of the first organizations in the U.S. to use BlindSquare, an innovative wayfinding technology. Bosma is using BlindSquare to help clients and employees better navigate its new, state-of-the-art headquarters, which opened June 2, and is representative of the nonprofit’s mission to assist people who are blind or visually impaired gain the life skills they need to remain independent, and the job skills they need to stay self-sufficient.
To view the multimedia release go to:
https://www.multivu.com/players/English/8116051-bosma-enterprises-blindsquare-mobile-navigation-technology/
For more than 60 years, Denny’s has been feeding America whatever they want, whenever they want it. Now, with ‘Denny’s on Demand’ fans can order the diner food they crave, wherever they crave it. Starting today, America can enjoy Denny’s anywhere thanks to the new ordering platform, offering guests a quick and easy way to place a mobile or online order for takeout or delivery* of their favorite menu items. Whether it’s pancakes by the pool, burgers on the beach or coffee on the couch, Denny’s is bringing the diner right to your door, 24/7.
To view the multimedia release go to:
https://www.multivu.com/players/English/8102451-dennys-launches-dennys-on-demand/
GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, along with its U.S. subsidiary Greenwich Biosciences, announced today that The New England Journal of Medicine has published results from a Phase 3 study of Epidiolex® (cannabidiol) in children with Dravet syndrome.1 Epidiolex, GW’s lead product candidate and the potential first in a new category of anti-epileptic drugs, is a liquid formulation of purified, plant-derived cannabidiol (CBD), a non-psychoactive cannabinoid, which is being studied for the treatment of a number of rare, severe pediatric-onset epilepsy disorders. In the study, Epidiolex significantly reduced monthly convulsive seizure frequency compared to placebo in highly treatment-resistant children when added to existing treatment. Treatment with Epidiolex was generally well tolerated, with a safety profile consistent with prior open label experience.
To view the multimedia release go to:
https://www.multivu.com/players/uk/8109951-gw-pharmaceuticals-study-epidiolex/
